These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10575135)

  • 21. Determination of the CCR5∆32 frequency in Emiratis and Tunisians and the screening of the CCR5 gene for novel alleles in Emiratis.
    Al-Jaberi SA; Ben-Salem S; Messedi M; Ayadi F; Al-Gazali L; Ali BR
    Gene; 2013 Oct; 529(1):113-8. PubMed ID: 23933274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.
    Li C; Yan YP; Shieh B; Lee CM; Lin RY; Chen YM
    J Formos Med Assoc; 1997 Dec; 96(12):979-84. PubMed ID: 9444918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.
    Gorry PR; Dunfee RL; Mefford ME; Kunstman K; Morgan T; Moore JP; Mascola JR; Agopian K; Holm GH; Mehle A; Taylor J; Farzan M; Wang H; Ellery P; Willey SJ; Clapham PR; Wolinsky SM; Crowe SM; Gabuzda D
    Virology; 2007 May; 362(1):163-78. PubMed ID: 17239419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.
    Morawetz RA; Rizzardi GP; Glauser D; Rutschmann O; Hirschel B; Perrin L; Opravil M; Flepp M; von Overbeck J; Glauser MP; Ghezzi S; Vicenzi E; Poli G; Lazzarin A; Pantaleo G
    Eur J Immunol; 1997 Dec; 27(12):3223-7. PubMed ID: 9464809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor.
    Park IW; Koziel H; Hatch W; Li X; Du B; Groopman JE
    Am J Respir Cell Mol Biol; 1999 May; 20(5):864-71. PubMed ID: 10226056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production.
    Yang JY; Togni M; Widmer U
    Cytokine; 1999 Jan; 11(1):1-7. PubMed ID: 10080873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.
    Quillent C; Oberlin E; Braun J; Rousset D; Gonzalez-Canali G; Métais P; Montagnier L; Virelizier JL; Arenzana-Seisdedos F; Beretta A
    Lancet; 1998 Jan; 351(9095):14-8. PubMed ID: 9433423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines.
    Wang J; Crawford K; Yuan M; Wang H; Gorry PR; Gabuzda D
    J Infect Dis; 2002 Apr; 185(7):885-97. PubMed ID: 11920312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
    Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
    Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b.
    Wimmer J; Fujinaga K; Taube R; Cujec TP; Zhu Y; Peng J; Price DH; Peterlin BM
    Virology; 1999 Mar; 255(1):182-9. PubMed ID: 10049833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
    Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotyping of CCR5 gene, CCR2b and SDF1 variants related to HIV-1 infection in Gabonese subjects.
    Mombo LE; Bisseye C; Mickala P; Ossari S; Makuwa M
    Intervirology; 2015; 58(1):22-6. PubMed ID: 25592723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia.
    Bol SM; Booiman T; van Manen D; Bunnik EM; van Sighem AI; Sieberer M; Boeser-Nunnink B; de Wolf F; Schuitemaker H; Portegies P; Kootstra NA; van 't Wout AB
    PLoS One; 2012; 7(2):e30990. PubMed ID: 22347417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency Virus (HIV) type 1 replication but not HIV entry into human monocytes.
    Creery D; Weiss W; Graziani-Bowering G; Kumar R; Aziz Z; Angel JB; Kumar A
    Viral Immunol; 2006; 19(3):409-23. PubMed ID: 16987060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
    Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
    Hladik F; Liu H; Speelmon E; Livingston-Rosanoff D; Wilson S; Sakchalathorn P; Hwangbo Y; Greene B; Zhu T; McElrath MJ
    J Virol; 2005 Sep; 79(18):11677-84. PubMed ID: 16140745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.
    Sophie M; Hameed A; Muneer A; Samdani AJ; Saleem S; Azhar A
    J Cutan Pathol; 2016 Jul; 43(7):564-70. PubMed ID: 26970327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
    Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
    J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.